Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1963 2
1966 1
1967 2
1968 3
1969 1
1970 3
1971 2
1972 1
1974 2
1975 1
1976 3
1977 1
1978 2
1979 5
1980 6
1981 12
1982 12
1983 9
1984 16
1985 24
1986 30
1987 20
1988 33
1989 31
1990 39
1991 35
1992 46
1993 38
1994 48
1995 53
1996 52
1997 53
1998 37
1999 54
2000 56
2001 68
2002 63
2003 54
2004 54
2005 76
2006 69
2007 86
2008 74
2009 87
2010 64
2011 57
2012 68
2013 82
2014 56
2015 65
2016 56
2017 79
2018 78
2019 81
2020 97
2021 80
2022 80
2023 76
2024 44

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,233 results

Results by year

Filters applied: . Clear all
Page 1
Guidelines for the medical management of pediatric vesicoureteral reflux.
Miyakita H, Hayashi Y, Mitsui T, Okawada M, Kinoshita Y, Kimata T, Koikawa Y, Sakai K, Satoh H, Tokunaga M, Naitoh Y, Niimura F, Matsuoka H, Mizuno K, Kaneko K, Kubota M. Miyakita H, et al. Among authors: matsuoka h. Int J Urol. 2020 Jun;27(6):480-490. doi: 10.1111/iju.14223. Epub 2020 Apr 1. Int J Urol. 2020. PMID: 32239562 Free PMC article.
Modified XELIRI (capecitabine plus irinotecan) versus FOLFIRI (leucovorin, fluorouracil, and irinotecan), both either with or without bevacizumab, as second-line therapy for metastatic colorectal cancer (AXEPT): a multicentre, open-label, randomised, non-inferiority, phase 3 trial.
Xu RH, Muro K, Morita S, Iwasa S, Han SW, Wang W, Kotaka M, Nakamura M, Ahn JB, Deng YH, Kato T, Cho SH, Ba Y, Matsuoka H, Lee KW, Zhang T, Yamada Y, Sakamoto J, Park YS, Kim TW. Xu RH, et al. Among authors: matsuoka h. Lancet Oncol. 2018 May;19(5):660-671. doi: 10.1016/S1470-2045(18)30140-2. Epub 2018 Mar 16. Lancet Oncol. 2018. PMID: 29555258 Clinical Trial.
Coping well.
Tu TTH, Toyofuku A, Matsuoka H. Tu TTH, et al. Among authors: matsuoka h. Br Dent J. 2020 Jul;229(2):70. doi: 10.1038/s41415-020-1931-x. Br Dent J. 2020. PMID: 32710019 Free PMC article. No abstract available.
Isolated Left Atrial Infective Mural Endocarditis.
Hosokawa S, Okayama H, Hiasa G, Kawamura G, Shigematsu T, Takahashi T, Kawada Y, Yamada T, Matsuoka H, Kazatani Y. Hosokawa S, et al. Among authors: matsuoka h. Intern Med. 2018 Apr 1;57(7):957-960. doi: 10.2169/internalmedicine.9559-17. Epub 2017 Dec 8. Intern Med. 2018. PMID: 29225261 Free PMC article. Review.
[Hypertension].
Matsuoka H. Matsuoka H. Nihon Naika Gakkai Zasshi. 2009 Jan 10;98(1):167-72. doi: 10.2169/naika.98.167. Nihon Naika Gakkai Zasshi. 2009. PMID: 19338099 Review. Japanese. No abstract available.
[Hypertension].
Matsuoka H. Matsuoka H. Nihon Ronen Igakkai Zasshi. 1996 Apr;33(4):245-8. Nihon Ronen Igakkai Zasshi. 1996. PMID: 8752709 Review. Japanese. No abstract available.
2,233 results